nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts
|
Pang, K. Sandy |
|
2007 |
9 |
2 |
p. E268-E283 |
artikel |
2 |
Appropriate calibration curve fitting in ligand binding assays
|
Findlay, John W. A. |
|
2007 |
9 |
2 |
p. E260-E267 |
artikel |
3 |
Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples
|
Nowatzke, William |
|
2007 |
9 |
2 |
p. E117-E122 |
artikel |
4 |
Biodegradable intraprostatic doxorubicin implants
|
Ortiz, Ronnie |
|
2007 |
9 |
2 |
p. E241-E250 |
artikel |
5 |
Brain natriuretic peptide: Potential adjunct for cardiac risk assessment and management during treatment with experimental anticancer agents
|
Varterasian, Mary L. |
|
2007 |
9 |
2 |
p. E115-E116 |
artikel |
6 |
Characterization of a cyclosporine solid dispersion for inhalation
|
Zijlstra, Gerrit S. |
|
2007 |
9 |
2 |
p. E190-E199 |
artikel |
7 |
Critical ligand binding reagent preparation/selection: When specificity depends on reagents
|
Rup, Bonita |
|
2007 |
9 |
2 |
p. E148-E155 |
artikel |
8 |
2007 highlights of advances in the pharmaceutical sciences: An American Association of Pharmaceutical Scientists (AAPS) perspective
|
Martinez, Marilyn N. |
|
2007 |
9 |
2 |
p. E219-E226 |
artikel |
9 |
Key elements of bioanalytical method validation for macromolecules
|
Kelley, Marian |
|
2007 |
9 |
2 |
p. E156-E163 |
artikel |
10 |
Nanosystems for simultaneous imaging and drug delivery to T cells
|
Fahmy, Tarke M. |
|
2007 |
9 |
2 |
p. E171-E180 |
artikel |
11 |
O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII
|
Miclea, Razvan D. |
|
2007 |
9 |
2 |
p. E251-E259 |
artikel |
12 |
Partial derivative—Based sensitivity analysis of models describing target-mediated drug disposition
|
Abraham, Anson K. |
|
2007 |
9 |
2 |
p. E181-E189 |
artikel |
13 |
Polymer-drug conjugates as modulators of cellular apoptosis
|
Vicent, Maria J. |
|
2007 |
9 |
2 |
p. E200-E207 |
artikel |
14 |
Population pharmacokinetics of S(−)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemate
|
Othman, Ahmed A. |
|
2007 |
9 |
2 |
p. E208-E218 |
artikel |
15 |
Procedural elements involved in maintaining bioanalytical data integrity for good laboratory practices studies and regulated clinical studies
|
James, Christopher A. |
|
2007 |
9 |
2 |
p. E123-E127 |
artikel |
16 |
Reproductible production of a PEGylated dual-acting peptide for diabetes
|
Tom, Irene |
|
2007 |
9 |
2 |
p. E227-E234 |
artikel |
17 |
Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins
|
Lee, Jean |
|
2007 |
9 |
2 |
p. E164-E170 |
artikel |
18 |
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
|
Torchilin, Vladimir P. |
|
2007 |
9 |
2 |
p. E128-E147 |
artikel |
19 |
Varying polymer architecture to deliver drugs
|
Heath, Felicity |
|
2007 |
9 |
2 |
p. E235-E240 |
artikel |